Publications by authors named "E Sehayek"

Objective: Previous studies have shown ezetimibe treatment results in a 2-6-fold increase in reverse cholesterol transport (RCT). However, recent sterol balance studies question the role of biliary sterol secretion in RCT, and challenge the hypothesis that ezetimibe increases RCT through decreased absorption of biliary cholesterol in the intestine. We set out to determine whether ezetimibe may increase RCT by mechanisms that are independent of its well-established inhibition of intestinal cholesterol absorption.

View Article and Find Full Text PDF

Aims: Epidemiological and animal studies have shown that maternal diet can influence metabolism in adult offspring. However, the molecular mechanisms underlying these changes remain poorly understood. Here, we characterize the phenotypes induced by maternal obesity in a mouse model and examine gene expression and epigenetic changes induced by maternal diet in adult offspring.

View Article and Find Full Text PDF

Background: The absorption of dietary long chain fatty acids (LCFA) largely occurs in the jejunum. LCFA are activated via conjugation with Coenzyme A (CoA), a reaction catalyzed by Acyl-CoA synthetases (ACS). Acyl-CoA sythesis is critical for dietary LCFA absorption; yet, the jejunal ACS enzymes that catalyze the reaction are largely unknown.

View Article and Find Full Text PDF
Article Synopsis
  • A study using a specific mouse intercross identified a region on chromosome 14 that affects cholesterol absorption based on gender.
  • Congenic animal studies showed that this region has multiple genetic factors leading to differing effects on cholesterol absorption in females compared to males.
  • Fine-mapping revealed a 6.3 Mb interval, where female subcongenic mice exhibited a 33% reduction in cholesterol absorption, linked to the candidate gene Ctsb, although further analysis suggested Ctsb might not be responsible for the observed effects.
View Article and Find Full Text PDF

Recent epidemiologic data show that low serum cholesterol level as well as statin use is associated with a decreased risk of developing aggressive or advanced prostate cancer, suggesting a role for cholesterol in aggressive prostate cancer development. Intracellular cholesterol promotes prostate cancer progression as a substrate for de novo androgen synthesis and through regulation of AKT signaling. By conducting next-generation sequencing-based DNA methylome analysis, we have discovered marked hypermethylation at the promoter of the major cellular cholesterol efflux transporter, ABCA1, in LNCaP prostate cancer cells.

View Article and Find Full Text PDF